Personalis, Inc. (PSNL) Financials
PSNL Assets vs Liabilities
Date | Assets | Liabilities |
---|---|---|
2023-12-31 | 225.1 million | 95.7 million |
2023-09-30 | 226.6 million | 75.4 million |
2023-06-30 | 249.0 million | 73.0 million |
2023-03-31 | 272.2 million | 78.5 million |
PSNL Free Cash Flow and Stock based compensation
Graph available only for supporters. Become a supporter to see it.
Date | Free Cash Flow | Stock based compensation |
---|---|---|
2023-12-31 | -16.9 million | 3.4 million |
2023-09-30 | -17.5 million | 3.5 million |
2023-06-30 | -13.2 million | 3.5 million |
2023-03-31 | -19.5 million | 3.7 million |
PSNL Net Income
No data available :(
PSNL Cash and Debt
Graph available only for supporters. Become a supporter to see it.
Date | Cash | Debt | Capital Lease |
---|---|---|---|
2023-12-31 | 114.2 million | - | 46.1 million |
2023-09-30 | 120.7 million | - | 39.2 million |
2023-06-30 | 137.2 million | - | 48.0 million |
2023-03-31 | 148.9 million | - | 46.8 million |
PSNL Shares Outstanding
PSNL Expenses
Graph available only for supporters. Become a supporter to see it.
Date | Capex | R&D | G&A | S&M |
---|---|---|---|---|
2023-12-31 | 3.5 million | 13.6 million | 11.5 million | - |
2023-09-30 | 868000 | 16.7 million | 12.0 million | - |
2023-06-30 | 2.7 million | 17.9 million | 12.1 million | - |
2023-03-31 | 3.8 million | 16.6 million | 14.1 million | - |
PSNL Cost of Revenue
Graph available only for supporters. Become a supporter to see it.
Date | Revenue | Cost of Revenue |
---|---|---|
2023-12-31 | 19.7 million | 14.5 million |
2023-09-30 | 18.2 million | 14.8 million |
2023-06-30 | 16.7 million | 11.9 million |
2023-03-31 | 18.9 million | 14.1 million |
PSNL
Price: $1.56
52 week price:
Earnings Per Share: -2.25 USD
P/E Ratio: -0.50
Exchange: NGM
Sector: Healthcare
Industry: Diagnostics & Research
Volume: 192700
Market Capitalization: 71.7 million